PAD plus lenalidomide in multiple myeloma - a promising four-drug regimen in newly diagnosed and advanced disease

被引：0
|
作者：
Schreder, M. [1 ]
Danhof, S. [1 ]
Rasche, L. [1 ]
Strifler, S. [1 ]
Einsele, H. [1 ]
Knop, S. [1 ]
机构：
[1] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P870
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Four-Drug Therapy for Multiple Myeloma
    Sonneveld, Pieter
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (15): : 1440 - 1441
  • [2] Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
    Jasielec, Jagoda K.
    Kubicki, Tadeusz
    Raje, Noopur
    Vij, Ravi
    Reece, Donna
    Berdeja, Jesus
    Derman, Benjamin A.
    Rosenbaum, Cara A.
    Richardson, Paul
    Gurbuxani, Sandeep
    Major, Sarah
    Wolfe, Brittany
    Stefka, Andrew T.
    Stephens, Leonor
    Tinari, Kathryn M.
    Hycner, Tyler
    Rojek, Alexandra E.
    Dytfeld, Dominik
    Griffith, Kent A.
    Zimmerman, Todd M.
    Jakubowiak, Andrzej J.
    BLOOD, 2020, 136 (22) : 2513 - 2523
  • [3] Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
    Jakubowiak, Andrzej
    Usmani, Saad Z.
    Krishnan, Amrita
    Lonial, Sagar
    Comenzo, Raymond L.
    Wang, Jianping
    de Boer, Carla
    Deraedt, William
    Weiss, Brendan M.
    Schecter, Jordan M.
    Chari, Ajai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 701 - 710
  • [4] Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
    Kate Matthews
    Nature Clinical Practice Oncology, 2006, 3 (3): : 116 - 117
  • [5] Efficacy and safety of a modified DVD regimen followed by lenalidomide for the treatment of Newly Diagnosed Multiple Myeloma
    Li, Zhichao
    Zhang, Wenhao
    Huang, Fang
    Hao, Siguo
    CLINICS, 2025, 80
  • [6] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Hajek, Roman
    Delforge, Michel
    Kropff, Martin
    Petrucci, Maria Teresa
    Catalano, John
    Gisslinger, Heinz
    Wiktor-Jedrzejczak, Wieslaw
    Zodelava, Mamia
    Weisel, Katja
    Cascavilla, Nicola
    Iosava, Genadi
    Cavo, Michele
    Kloczko, Janusz
    Blade, Joan
    Beksac, Meral
    Spicka, Ivan
    Plesner, Torben
    Radke, Joergen
    Langer, Christian
    Ben Yehuda, Dina
    Corso, Alessandro
    Herbein, Lindsay
    Yu, Zhinuan
    Mei, Jay
    Jacques, Christian
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19): : 1759 - 1769
  • [7] Lenalidomide: The optimal choice in newly diagnosed multiple myeloma
    Palumbo, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 271 - 271
  • [8] Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma
    Laubach, Jacob P.
    Schlossman, Robert L.
    Mitsiades, Constantine S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 51 - 60
  • [9] Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
    Kumar, Shaji K.
    Kapoor, Prashant
    Laplant, Betsy
    Phuong-Dung, Liang
    Muchtar, Eli
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Malave, Gabriella C.
    Vossen, Alanna M.
    Dingli, David
    Go, Ronald S.
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Lust, John A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    BLOOD, 2020, 136
  • [10] Lenalidomide as maintenance for every newly diagnosed patient with multiple myeloma
    Mateos, Maria-Victoria
    Gonzalez de la Calle, Veronica
    LANCET ONCOLOGY, 2019, 20 (01): : 5 - 6
12345